Activation of natural killer T cells by α-galactosylceramide mediates clearance of bacteria in murine urinary tract infection

Journal of Urology

Volumn 173, Issue 6, 2005, Pages 2171-2174

  Minagawa, Shingo ^a   Ohyama, Chikara ^b   Hatakeyama, Shingo ^a   Tsuchiya, Norihiko ^a   Kato, Tetsuro ^a   Habuchi, Tomonori ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

Author keywords

Alpha galactosylceramide; Kidney; Killer cells, natural; Macrophages; Urinary tract infections

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; ALPHA MANNOSYLCERAMIDE; ANTIINFECTIVE AGENT; CD1D ANTIGEN; GAMMA INTERFERON; GLYCOLIPID; INTERLEUKIN 12; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOMETRY; ESCHERICHIA COLI; FEMALE; INFECTION PREVENTION; INOCULATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; T LYMPHOCYTE; TISSUE HOMOGENATE; URINARY TRACT INFECTION;

EID: 18744372448     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000158122.16046.68     Document Type: Article

References (19)

1. Skold, M. and Behar, S. M.: Role of CD1d-restricted NKT cells in microbial immunity. Infect Immun, 71: 5447, 2003
2. Fujii, S., Shimizu, K., Kronenberg, M. and Steinman, R. M.: Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs. Nat Immunol, 3: 867, 2002
3. Morita, M., Motoki, K., Akimoto, K., Natori, T., Sakai, T., Sawa, E. et al: Structure-activity relationship of alpha-galactosylceramides against B16-bearing mice. J Med Chem, 38: 2176, 1995
4. Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K. et al: CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science, 278: 1626, 1997
5. Nieuwenhuis, E. E., Matsumoto, T., Exley, M., Schleipman, R. A., Glickman, J., Bailey, D. T. et al: CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nat Med, 8: 588, 2002
6. Kawakami, K., Kinjo, Y., Yara, S., Koguchi, Y., Uezu, K., Nakayama, T. et al: Activation of Valpha14(+) natural killer T cells by alpha- galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans. Infect Immun, 69: 213, 2001
7. Brigl, M., Bry, L., Kent, S. C., Gumperz, J. E. and Brenner, M. B.: Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat Immunol, 4: 1230, 2003
8. Cui, J., Shin, T., Kawano, T., Sato, H., Kondo, E., Toura, I. et al: Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science, 278: 1623, 1997
9. Ishikawa, H., Hisaeda, H., Taniguchi, M., Nakayama, T., Sakai, T., Maekawa, Y. et al: CD4(+) v(alpha)14 NKT cells play a crucial role in an early stage of protective immunity against infection with Leishmania major. Int Immunol, 12: 1267, 2000
10. Kawakami, K., Yamamoto, N., Kinjo, Y., Miyagi, K., Nakasone, C., Uezu, K. et al: Critical role of Valpha14+ natural killer T cells in the innate phase of host protection against Streptococcus pneumoniae infection. Eur J Immunol, 33: 3322, 2003
11. Bendelac, A., Rivera, M. N., Park, S. H. and Roark, J. H.: Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu Rev Immunol, 15: 535, 1997
12. Taniguchi, M., Harada, M., Kojo, S., Nakayama, T. and Wakao, H.: The regulatory role of Valpha14 NKT cells in innate and acquired immune response. Annu Rev Immunol, 21: 483, 2003
13. Hayakawa, Y., Takeda, K., Yagita, H., Smyth, M. J., Van Kaer, L., Okumura, K. et al: IFN-gamma-mediated inhibition of tumor angiogenesis by natural killer T-cell ligand, alpha-galactosylceramide. Blood, 100: 1728, 2002
14. Duthie, M. S. and Kahn, S. J.: Treatment with alpha-galactosylceramide before Trypanosoma cruzi infection provides protection or induces failure to thrive. J Immunol, 168: 5778, 2002
15. Marcus, E, L., Altmark, L., Shapiro, M. and Moses, A. E.: Antimicrobial resistance patterns among urine isolates from patients in a geriatric hospital and from older patients in a general hospital in Jerusalem. J Am Med Dir Assoc, 2: 34, 2001
16. Samuelsson, P., Hang, L., Wullt, B., Irjala, H. and Svanborg, C.: Toll-like receptor 4 expression and cytokine responses in the human urinary tract mucosa. Infect Immun, 72: 3179, 2004
17. Brigl, M. and Brenner, M. B.: CD1: Antigen presentation and T cell function. Annu Rev Immunol, 22: 817, 2004
18. Tomura, M., Yu, W. G., Ahn, H. J., Yamashita, M., Yang, Y. F., Ono, S. et al: A novel function of Valpha14 + CD4 + NKT cells: Stimulation of IL-12 production by antigen-presenting cells in the innate immune system. J Immunol, 163: 93, 1999
19. Kitamura, H., Iwakabe, K., Yahata, T., Nishimura, S., Ohta, A., Ohmi, Y. et al: The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J Exp Med, 189: 1121, 1999